March 8, 2017
The University of Pittsburgh Innovation Institute reported that Pitt Innovators were issued 8 U.S. patents in February 2017.
Featured Patents
US 9,561,497 "Non-Noble Metal Based Electro-Catalyst Compositions for Proton Exchange Membrane Based Water Electrolysis and Methods of Making"
Prashant Kumta, the Edward R. Weidlein Chair Professor at Swanson School of Engineering and School of Dental Medicine and his colleagues Moni Datta, engineering research assistant professor, and research assistant Karan Kadakia, research assistant professor Oleg Velikokhatnyi and doctoral student Prashanth Hanumantha, have developed electro-catalyst compositions including a combination of noble metal and non-noble metal oxides for proton exchange membrane-based water electrolysis, and methods of preparing the electro-catalyst compositions and forming electrodes therefrom. For more information on this technology, contact Janice Panza.
US 9,562,066 "Oral Therapy of Necrotizing Enterocolitis"
David Hackam, former professor of surgery, cell biology and physiology, developed a method of reducing the risk of necrotizing enterocolitis (NEC), which is the leading cause of death from gastrointestinal disease in neonatal children, through the oral delivery of a compound, CpG-ODN. The most recent patent adds to an expanding portfolio of patents at Pitt for treating NEC. For more information on this technology, contact Maria Vanegas.
Below is a listing of all patents received by Pitt Innovators in February 2017.
| Patent Number |
Title | Inventor(s) | Licensing Manager | Status | ||
| 9,561,497 | Non-Noble Metal Based Electro-Catalyst Compositions for Proton Exchange Membrane Based Water Electrolysis and Methods of Making | Moni Datta; Karan Kadakia; Prashant Kumta; Oleg Velikokhatnyi; Prashanth Hanumantha | Janice Panza | Available for Licensing |
||
| 9,562,066 | Oral Therapy of Necrotizing Enterocolitis | David Hackam | Maria Vanegas | Available for Licensing |
||
| 9,567,638 | Methods and Compositions for Diagnosing Renal Disease and Hyperuricemia | Thomas Hart; Anthony Bleyer; Michael Gorry; Patricia Hart | Alex Ducruet | Licensed | ||
| 9,566,327 | Computationally Optimized Broadly Reactive Antigens for Human and Avian H5N1 Influenza | Ted Ross; Corey Crevar; Brendan Giles | Andrew Remes | Licensed | ||
| 9,566,043 | Sensor Guided Catheter Navigation System | David Schwartzman; Takeo Kanade; Hua Zhong; | Alex Ducruet | Licensed | ||
| 9,566,328 | Computationally Optimized Broadly Reactive Antigens for H1N1 Influenza | Corey Crevar; Ted Ross; Donald Carter | Andrew Remes | Licensed | ||
| 9,580,475 | Computationally Optimized Broadly Reactive Antigens for H1N1 Influenza | Corey Crevar; Ted Ross | Andrew Remes | Licensed | ||
| 9,580,699 | A TRPV1 Modulatory Gene Product That Affects TRPV1-Specific Pain Behavioral Responses Identified in a Functional Screen of an HSV-Based cDNA Library | William Goins; Joseph Glorioso; Justus Cohen; Bonnie Reinhart | Maria Vanegas | Licensed | ||